Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Sci-Tech Press Austria.
Powder Metallurgy Market to Hit USD 7.68 Bn by 2032, Growing at 12% CAGR Maximize Market Research
EIN Presswire
·
September 12, 2025
In 2024, the North American powder metallurgy market emerged as the top revenue generator with a market share of nearly 38% WILMINGTON, DE, UNITED STATES, September 12, 2025 /EINPresswire.com/ -- Powder Metallurgy Industry Overview The Powder...
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
GlobeNewswire, Inc.
·
September 11, 2025
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from...
Biomethane Market Growing at 6.08% CAGR to Reach USD 9.23 Billion by 2032 Maximize Market Research
EIN Presswire
·
September 11, 2025
The German biomethane market has emerged as a highly attractive sector due to its dynamic regulatory framework and evolving market conditions. WILMINGTON, DE, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- Biomethane Industry Overview...
AV-Comparatives Nominated for Euregio Innovation Award at European Forum Alpbach 2025
EIN Presswire
·
September 13, 2025
Research uncovers serious vulnerabilities across multiple devices from two major smart home vendors, underscoring the need for IoT and OT security standards. ALPBACH, AUSTRIA, TIROL, AUSTRIA, September 13, 2025 /EINPresswire.com/ --...
Leading Austrian Pathology Laboratory Group Chooses PathAI’s AISight® Dx to Accelerate Digital Pathology and Advanced Diagnostics
GlobeNewswire, Inc.
·
September 8, 2025
BOSTON and VIENNA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence and digital pathology solutions, today announced multi-year partnerships with a group of pioneering Austrian pathology laboratories to deploy...
Biomed Industries to Present Phase 2 Results on NA-931-An Oral Alternative to Injectables for Obesity- EASD 2025 Austria
EIN Presswire
·
September 8, 2025
Biomed Industries, Inc. to Present Phase 2 Results on NA-931-a First-in Class Alternative to Injectables for the Treatment of Obesity-EASD 2025- Vienna-Austria SAN JOSE, CA, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Biomed...
CEU Scholar Alexander Bor Awarded Prestigious ERC Starting Grant for Groundbreaking Democracy Research
EIN Presswire
·
September 4, 2025
VIENNA, AUSTRIA, September 4, 2025 /EINPresswire.com/ -- Central European University (CEU) is proud to announce that Alexander Bor, ERA Research Fellow at the CEU Democracy Institute, has been awarded the European Research Council (ERC) Starting...
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
GlobeNewswire, Inc.
·
August 25, 2025
TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,...
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
GlobeNewswire, Inc.
·
August 29, 2025
Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI tested whether home-based, self-applied use of...
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
GlobeNewswire, Inc.
·
August 27, 2025
Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs BERKELEY, Calif, Aug. 27, 2025 (GLOBE NEWSWIRE) --...
Progress in clinical development for Alzheimer’s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
GlobeNewswire, Inc.
·
September 12, 2025
GAL-101 was well tolerated; excellent safety and pharmacokinetic profile strongly support oral administration GAL-101 effectively crosses the blood-brain barrier, supporting further development in Alzheimer’s disease A Phase 2 trial in Alzheimer’s...
Germany wants to eliminate reliance on US tech leading firm
MENAFN
·
August 24, 2025
(MENAFN) Germany is weighing a move away from Microsoft products in favor of open-source solutions, part of a wider effort to strengthen digital independence and reduce reliance on US tech companies, Bild reported Wednesday. The Federal Ministry...
Surgical Mesh Implants Market to Exceed US $5.13 Billion by 2029, with 0% CAGR: The Business Research Company
EIN Presswire
·
August 22, 2025
The Business Research Company's Surgical Mesh Implants Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 22, 2025 /EINPresswire.com/ -- What Is The Forecast For The...
NANO Nuclear to be Featured in Upcoming Nuclear Energy Industry Events
GlobeNewswire, Inc.
·
September 11, 2025
New York, N.Y., Sept. 11, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced its...
Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030
GlobeNewswire, Inc.
·
August 19, 2025
Boston, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Tissue Engineering and Regeneration: Technologies and Global Markets” is estimated to increase from $5.4 billion in 2025 to $9.8 billion by the end of...
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
GlobeNewswire, Inc.
·
September 11, 2025
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain...
Printed Circuit Board Market for Electric Vehicles Projected to Reach US$ 4.4 Bn by 2035, Growing at 8.5% CAGR | TMR
EIN Presswire
·
September 10, 2025
Global EV PCB market to hit US$ 4.4 Bn by 2035, fueled by EV supply chain investments, autonomous tech, and demand for flexible PCB solutions. WILMINGTON, DE, UNITED STATES, September 10, 2025 /EINPresswire.com/ -- The global transition toward...
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
GlobeNewswire, Inc.
·
September 10, 2025
LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi® saypha® MagIQ™ injectable...
MOCAMAG Museum displays art of the 20th and 21st centuries
EIN Presswire
·
September 8, 2025
AUSTRIA, September 8, 2025 /EINPresswire.com/ -- On September 6, four exhibitions were celebrated at the MOCAMAG Contemporary Art Museum in Persenbeug. The MOCAMAG Museum presents four exhibitions until October 7, 2025. Visitors can expect a...
Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients
GlobeNewswire, Inc.
·
September 8, 2025
Enables biopharmaceutical companies to accelerate precision drug development by delivering real-time patient insights from a global laboratory network on track to diagnose 8 million pathology cases annually. Opens new streams of revenue for...